Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Summary

Kala Bio and Virotek have finalized a definitive agreement establishing an exclusive U.S. distribution partnership for Virotek's ophthalmology genomic testing program, granting Kala exclusive rights to market and distribute the testing program in the United States.